UNITED KINGDOM–(ENEWSPF)–5 May 2011. A new drug for the muscle-wasting disease Duchenne muscular dystrophy has shown significant benefits in mice, opening the door for clinical trials.
The promising results indicate that a simple, daily pill to treat all patients with Duchenne muscular dystrophy should be possible, whether or not this specific drug formulation makes it all the way through clinical trials without further development.
The study, led by researchers at Oxford University, the University of…
